论文部分内容阅读
目的观察贝那普利治疗慢性心力衰竭患者的临床效果。方法选择医院收治的慢性心力衰竭患者60例,按治疗方法分为观察组和对照组,每组30例。对照组采用常规药物进行治疗,观察组在对照组基础上给予贝那普利治疗。观察2组临床疗效、不良事件发生情况,分析治疗前、后6 min步行试验、心功能级别和心功能指标的改善情况。结果观察组治疗后总有效率高于对照组,不良事件发生率低于对照组(P<0.05);治疗后2组6 min步行试验、心功能级别和心功能指标均较治疗前改善,且观察组改善情况优于对照组(P<0.05)。结论贝那普利治疗慢性心力衰竭患者临床疗效确切,可有效改善患者心功能,降低心功能分级,且安全性较高。
Objective To observe the clinical effect of benazepril in patients with chronic heart failure. Methods Sixty patients with chronic heart failure admitted to the hospital were divided into observation group and control group according to the treatment method, with 30 cases in each group. The control group was treated with conventional drugs. The observation group received benazepril treatment on the basis of the control group. The clinical curative effect and incidence of adverse events in the two groups were observed. The improvement of walking function, cardiac function and cardiac function before and 6 minutes after treatment were analyzed. Results After treatment, the total effective rate in observation group was higher than that in control group, and the incidence of adverse events was lower than that in control group (P <0.05). After 6 minutes of treatment, the walking test, cardiac function level and cardiac function index improved in both groups The observation group improved better than the control group (P <0.05). Conclusion The clinical efficacy of benazepril in patients with chronic heart failure is accurate, which can effectively improve the cardiac function, reduce the classification of cardiac function, and have higher safety.